Published in Bull World Health Organ on January 01, 1997
The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J (2008) 2.23
Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 1.71
Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine (2012) 1.07
Antimicrobial resistance in human and animal pathogens in Zambia, Democratic Republic of Congo, Mozambique and Tanzania: an urgent need of a sustainable surveillance system. Ann Clin Microbiol Antimicrob (2013) 1.03
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in Zambia. Antimicrob Agents Chemother (2010) 1.03
Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008. Antimicrob Agents Chemother (2012) 0.86
Pneumococcal carriage in sub-Saharan Africa--a systematic review. PLoS One (2014) 0.85
Nasopharyngeal carriage rate of Streptococcus pneumoniae in Ugandan children with sickle cell disease. BMC Res Notes (2012) 0.82
A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP). BMC Infect Dis (2016) 0.82
High prevalence of antibiotic resistance in nasopharyngeal bacterial isolates from healthy children in rural Uganda: A cross-sectional study. Ups J Med Sci (2015) 0.76
The crisis in antibiotic resistance. Science (1992) 11.65
Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis (1980) 7.45
Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis (1983) 3.19
The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q (1992) 3.14
Pneumococcal disease: prospects for a new generation of vaccines. Science (1994) 2.48
Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med (1974) 2.46
Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis (1984) 1.98
Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J (1993) 1.95
Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am J Dis Child (1986) 1.55
Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clin Infect Dis (1992) 1.54
Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child (1992) 1.49
Increased incidence of tetracycline-resistant pneumococci in Liverpool in 1968. Lancet (1969) 1.46
Can antibiotic resistance be controlled? N Engl J Med (1994) 1.42
Chloramphenicol-resistant pneumococci in West Africa. Lancet (1978) 1.38
Comparison between parental report and results of microbiologic agar assay for presence of antibiotic in urine of Argentinian children with acute lower respiratory tract infection. Rev Infect Dis (1991) 0.94
Throat carriage of Streptococcus pneumoniae and Streptococcus pyogenes among infants and children in Zambia. J Trop Pediatr (1988) 0.91
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med (1997) 8.43
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet (2001) 4.33
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 3.37
Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis (2011) 2.77
Tuberculosis and HIV infection. Lancet (1993) 2.75
Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health (2001) 2.70
Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis (1999) 2.66
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS (1998) 2.35
Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis (1998) 2.27
Typhoid fever vaccines. Vaccine (1999) 2.18
High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis (2009) 2.06
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya. Lancet (1993) 2.01
Adverse reactions in expatriates treated with ivermectin. Lancet (1990) 1.98
Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med (1999) 1.97
Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis (1999) 1.82
Aeromonas species isolated from medicinal leeches. Ann Plast Surg (1999) 1.76
Diagnosis of pulmonary disease in human immunodeficiency virus infection: role of transbronchial biopsy and bronchoalveolar lavage. Thorax (1989) 1.72
Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis (2013) 1.70
Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatr Infect Dis J (2000) 1.69
Evaluation of the Etest as a means of determining the antibiotic susceptibilities of isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. J Antimicrob Chemother (2000) 1.67
Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS (2001) 1.63
Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. Antimicrob Agents Chemother (2001) 1.60
Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis (2011) 1.57
Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi. Int J Tuberc Lung Dis (2004) 1.55
Tuberculous pericarditis confirmed by DNA amplification. Lancet (1991) 1.54
Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clin Infect Dis (1992) 1.54
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS (2000) 1.52
Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis (2001) 1.52
An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. HIV Med (2000) 1.51
Defining and assessing the maximum number of visits patients should make to a health facility to obtain a diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis (2003) 1.44
Cluster of an erythromycin-resistant variant of the Spanish multiply resistant 23F clone of Streptococcus pneumoniae in South Africa. Eur J Clin Microbiol Infect Dis (1994) 1.42
Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ (2006) 1.41
Where is diabetes in The Lancet's tuberculosis Series? Lancet (2010) 1.39
HIV and tuberculosis in the commonwealth. BMJ (1999) 1.39
Comparison of four culture systems for Mycobacterium tuberculosis in the Zambian National Reference Laboratory. Int J Tuberc Lung Dis (2009) 1.37
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother (2002) 1.37
The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS (1998) 1.35
Polymerase chain reaction for detection of Mycobacterium tuberculosis in sputum. Eur J Clin Microbiol Infect Dis (1993) 1.35
Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Thorax (1989) 1.33
Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. Int J Tuberc Lung Dis (2008) 1.30
Characteristics, management and outcome of patients with recurrent tuberculosis under routine programme conditions in Malawi. Int J Tuberc Lung Dis (2003) 1.27
Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis (1997) 1.23
A multidisciplinary method to map potential tuberculosis transmission 'hot spots' in high-burden communities. Int J Tuberc Lung Dis (2009) 1.23
Carriage of penicillin resistant pneumococci. Arch Dis Child (1986) 1.20
Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country. Int J Tuberc Lung Dis (2008) 1.16
Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration. Int J Tuberc Lung Dis (1998) 1.16
Extra-pulmonary and smear-negative forms of tuberculosis are associated with treatment delay and hospitalisation. Int J Tuberc Lung Dis (2010) 1.14
Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. Bull World Health Organ (2009) 1.13
Intra-assay reliability and robustness of QuantiFERON(R)-TB Gold In-Tube test in Zambia. Int J Tuberc Lung Dis (2010) 1.11
Drug-resistant pulmonary tuberculosis in a cohort of southern African goldminers with a high prevalence of HIV infection. S Afr Med J (2000) 1.11
In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae. J Antimicrob Chemother (1995) 1.11
Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. Pediatr Infect Dis J (2000) 1.10
Simplification of the polymerase chain reaction for detection of Mycobacterium tuberculosis in the tropics. Trans R Soc Trop Med Hyg (1993) 1.09
The case for a family of reverse transcriptase viruses: Retraviridae. Intervirology (1974) 1.09
An incremental cost-effectiveness analysis of the first, second and third sputum examination in the diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.08
Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi. Int J Tuberc Lung Dis (2003) 1.04
Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high-risk population. Bull Pan Am Health Organ (1996) 1.04
Antibiotic susceptibility patterns of Streptococcus pneumoniae in china and comparison of MICs by agar dilution and E-test methods. Antimicrob Agents Chemother (1998) 1.04
Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya. AIDS (1997) 1.01
Impact of HIV infection on Zambian businesses. BMJ (1994) 1.01
Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect (2002) 1.00
Prevalence of serotypes and molecular epidemiology of Streptococcus pneumoniae strains isolated from children in Beijing, China: identification of two novel multiply-resistant clones. Microb Drug Resist (2001) 1.00
Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med (1996) 0.99
Auditing the new decentralised oral treatment regimens in Malawi. Int J Tuberc Lung Dis (2004) 0.99
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med (1998) 0.98
HIV counsellors' knowledge, attitudes and vulnerabilities to HIV in Lusaka, Zambia, 1994. AIDS Care (1996) 0.98
Risk factors for pulmonary disease due to culture-positive M. tuberculosis or nontuberculous mycobacteria in South African gold miners. Eur Respir J (2000) 0.98
Tuberculosis treatment failure and drug resistance--same strain or reinfection? Trans R Soc Trop Med Hyg (2001) 0.97
Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia. AIDS (1997) 0.96
Part IV. Human infections and antibiotic resistance. S Afr Med J (2011) 0.95
BCG and HIV reconsidered: moving the research agenda forward. Vaccine (2007) 0.94
Fatal infection caused by a multiply resistant type 3 pneumococcus. J Clin Microbiol (1988) 0.94
Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya. Int J Tuberc Lung Dis (2000) 0.93
Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa. J Infect (2008) 0.93
Economic barriers for tuberculosis patients in Zambia. Lancet (1996) 0.92
Children's role in enhanced case finding in Zambia. Int J Tuberc Lung Dis (2010) 0.92
Delays in seeking treatment for symptomatic tuberculosis in Sabah, East Malaysia: factors for patient delay. Int J Tuberc Lung Dis (2011) 0.90
Tuberculosis among community-based health care researchers. Int J Tuberc Lung Dis (2010) 0.87
Nasopharyngeal carriage and antimicrobial resistance in isolates of Streptococcus pneumoniae and Haemophilus influenzae type b in children under 5 years of age in Botswana. Int J Infect Dis (1999) 0.87
Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: implications for future immunization policies. Pediatr Infect Dis J (1994) 0.86
Knowledge and attitudes to HIV and AIDS and sexual practices among university students in Lusaka, Zambia and London, England: are they so different? J R Soc Health (1997) 0.85
Influenza guideline for South Africa--update 2008. S Afr Med J (2008) 0.85
Comparison of two bacteriophage tests and nucleic acid amplification for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis (2004) 0.83
Drug resistance is not the principal barrier to effective control of tuberculosis in Zambia. J Infect Dis (1994) 0.83
Molecular diagnosis of tuberculosis: the need for new diagnostic tools. Thorax (1995) 0.82
The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus. Proc Natl Acad Sci U S A (1977) 0.82
Horizontally transmitted lymphomas of Syrian hamsters. Fed Proc (1978) 0.82
The measurement of household socio-economic position in tuberculosis prevalence surveys: a sensitivity analysis. Int J Tuberc Lung Dis (2013) 0.81
Spontaneous tumors and C-type virus in polyoma-infected aging wild house mice. J Natl Cancer Inst (1974) 0.81
L2C/NB guinea pig leukemia: failure to demonstrate transmissible leukemogenic virus. Bibl Haematol (1970) 0.81
Non-Hodgkin's lymphoma associated with the acquired immune deficiency syndrome: a report of five cases. Radiother Oncol (1989) 0.81